13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 42 holding rows worth $435,118,234.
- Accession
- 0001172661-26-002272
- Filer
- CIK 1281446
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 42 entries on the cover page, a total value of $435,118,234 stated on the cover page (in dollars after the unit check, H1), rows summing to $435,118,234 with VALUE read as dollars as filed, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerNordahl Lillian028-24470
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 374,000 | $31,479,580 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 1,750,000 | $31,220,000 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 4,215,930 | $25,084,784 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,750,000 | $24,325,000 | dollars as filed | |
| IMMUNITYBIO INC | 45256X103 | COM | 3,000,800 | $23,016,136 | dollars as filed | put |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 316,453 | $22,768,793 | dollars as filed | |
| SOL-GEL TECHNOLOGIES LTD | M8694L137 | SHS NEW | 274,363 | $21,735,037 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 856,061 | $18,859,024 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 220,000 | $16,053,400 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 2,500,000 | $13,850,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 675,000 | $13,587,750 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 545,625 | $13,553,325 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 964,462 | $13,550,691 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 800,198 | $10,450,586 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 524,066 | $10,245,490 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 500,000 | $10,080,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 500,000 | $9,320,000 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 1,334,130 | $9,138,791 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 183,330 | $8,992,337 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 1,200,000 | $8,688,000 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 199,348 | $8,019,770 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 325,000 | $7,471,750 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 300,000 | $7,398,000 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,350,000 | $7,141,500 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 7,554,347 | $6,926,581 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 3,405,757 | $5,960,075 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 2,238,496 | $5,864,860 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 842,106 | $5,861,058 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,020,489 | $5,377,977 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 796,558 | $5,241,352 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 327,307 | $5,233,639 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 371,402 | $4,716,805 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 300,000 | $4,263,000 | dollars as filed | |
| IMMIX BIOPHARMA INC | 45258H106 | COMMON STOCK | 350,000 | $3,188,500 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 951,809 | $2,903,017 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 82,800 | $2,339,100 | dollars as filed | |
| HUMACYTE INC | 44486Q103 | COM | 3,750,000 | $2,275,125 | dollars as filed | |
| GALECTIN THERAPEUTICS INC | 363225202 | COMMON STOCK | 800,000 | $2,232,000 | dollars as filed | call |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 124,666 | $1,861,263 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 50,000 | $1,768,000 | dollars as filed | |
| ANAVEX LIFE SCIENCES CORP | 032797300 | COM NEW | 521,300 | $1,600,391 | dollars as filed | call |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 324,340 | $1,475,747 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-002272 | this filing | 2026-05-15 | acceptance time not in the bulk data set |